By providing clinicians with standardized measurements on their patients’ brain MRI scans, icometrix improves personalized care of people with a neurological disorder.
icometrix was founded in 2011 by Dirk Loeckx and Wim Van Hecke. It is a spin-off company of the universities and university hospitals of Leuven and Antwerp. Today, icometrix has grown to a team of over 25 people and is internationally active, with headquarters in Leuven and an office in Boston, USA. They are the worldwide standard in MRI biomarkers in routine clinical practice.
icometrix developed MSmetrix, which detects brain lesions, calculates lesion volume and measures the whole brain and grey matter volume and atrophy. MSmetrix, received market approval in the EU and other countries including Canada, Brazil and Australia. FDA clearance is pending for the US variant of our clinical reports, which is named icobrain. Furthermore, icometrix is ISO9001 and ISO13485 (Medical Devices) and ISO27001 (Information Security) certified.